AKT1 and Jeune syndrome: In conclusion, the PcActx peptide functions as a TRPV1 modulator of intercellular calcium homeostasis, inhibits ATD-like amyloid neuropathology through Akt/Gsk3-mediated NRF2 activation, and represents a potential alternative agent for the treatment of ATD.62